Resveratrol-induced SIRT1 activation promotes neuronal differentiation of human bone marrow mesenchymal stem cells

Neuroscience Letters

Volumn 584, Issue , 2015, Pages 97-102

  Joe, I Seul ^a   Jeong, Sin Gu ^a   Cho, Goang Won ^a  

^a Chosun University   (South Korea)

Author keywords

Bone marrow mesenchymal stem cells (BM MSCs); Neuronal differentiation; Resveratrol; Sirtuin1 (SIRT1)

Indexed keywords

ADIPONECTIN; CD133 ANTIGEN; COLLAGENASE 3; FATTY ACID BINDING PROTEIN 4; MICROTUBULE ASSOCIATED PROTEIN 2; MUSASHI PROTEIN; NESTIN; NEUROFILAMENT M PROTEIN; PROTEIN; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN; BIOLOGICAL MARKER; SIRT1 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROPROTECTION; PROTEIN EXPRESSION; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; NERVE CELL;

BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; NEURONS; SIRTUIN 1; STILBENES;

EID: 84908638621     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.10.024     Document Type: Article

References (28)

1. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
2. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
3. Dantuma E., Merchant S., Sugaya K. Stem cells for the treatment of neurodegenerative diseases. Stem Cell Res. Ther. 2010, 1:37.
4. Donmez G. The Effects of SIRT1 on Alzheimer's disease models. Int. J. Alzheimers Dis. 2012, 2012:509529.
5. Donmez G. The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol. Sci. 2012, 33:494-501.
6. Donmez G., Arun A., Chung C.Y., McLean P.J., Lindquist S., Guarente L. SIRT1 protects against alpha-synuclein aggregation by activating molecular chaperones. J. Neurosci. 2012, 32:124-132.
7. Donmez G., Wang D., Cohen D.E., Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010, 142:320-332.
8. Fan W., Cheng K., Qin X., Narsinh K.H., Wang S., Hu S., Wang Y., Chen Y., Wu J.C., Xiong L., Cao F. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo. Stem Cells 2013, 31:203-214.
9. Guo W., Qian L., Zhang J., Zhang W., Morrison A., Hayes P., Wilson S., Chen T., Zhao J. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J. Neurosci. Res. 2011, 89:1723-1736.
10. Han S., Choi J.R., Soon Shin K., Kang S.J. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. Brain Res. 2012, 1483:112-117.
11. Herskovits A.Z., Guarente L. SIRT1 in neurodevelopment and brain senescence. Neuron 2014, 81:471-483.
12. Holloway K.R., Calhoun T.N., Saxena M., Metoyer C.F., Kandler E.F., Rivera C.A., Pruitt K. SIRT1 regulates dishevelled proteins and promotes transient and constitutive Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9216-9221.
13. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
14. Hsu S.C., Huang S.M., Chen A., Sun C.Y., Lin S.H., Chen J.S., Liu S.T., Hsu Y.J. Resveratrol increases anti-aging Klotho gene expression via the activating transcription factor 3/c-Jun complex-mediated signaling pathway. Int. J. Biochem. Cell Biol. 2014, 53:361-371.
15. Jeong H., Cohen D.E., Cui L., Supinski A., Savas J.N., Mazzulli J.R., Yates J.R., Bordone L., Guarente L., Krainc D. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 2012, 18:159-165.
16. Jeong S.G., Ohn T., Kim S.H., Cho G.W. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells. Neurosci. Lett. 2013, 554:22-27.
17. Li X.H., Chen C., Tu Y., Sun H.T., Zhao M.L., Cheng S.X., Qu Y., Zhang S. Sirt1 promotes axonogenesis by deacetylation of Akt and inactivation of GSK3. Mol. Neurobiol. 2013, 48:490-499.
18. Milne J.C., Lambert P.D., Schenk S., Carney D.P., Smith J.J., Gagne D.J., Jin L., Boss O., Perni R.B., Vu C.B., Bemis J.E., Xie R., Disch J.S., Ng P.Y., Nunes J.J., Lynch A.V., Yang H., Galonek H., Israelian K., Choy W., Iffland A., Lavu S., Medvedik O., Sinclair D.A., Olefsky J.M., Jirousek M.R., Elliott P.J., Westphal C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 450:712-716.
19. Pallas M., Casadesus G., Smith M.A., Coto-Montes A., Pelegri C., Vilaplana J., Camins A. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr. Neurovasc. Res. 2009, 6:70-81.
20. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., Ke H., Rehmann H., Taussig R., Brown A.L., Kim M.K., Beaven M.A., Burgin A.B., Manganiello V., Chung J.H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
21. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
22. Price N.L., Gomes A.P., Ling A.J., Duarte F.V., Martin-Montalvo A., North B.J., Agarwal B., Ye L., Ramadori G., Teodoro J.S., Hubbard B.P., Varela A.T., Davis J.G., Varamini B., Hafner A., Moaddel R., Rolo A.P., Coppari R., Palmeira C.M., de Cabo R., Baur J.A., Sinclair D.A. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012, 15:675-690.
23. Ramprasath V.R., Jones P.J. Anti-atherogenic effects of resveratrol. Eur. J. Clin. Nutr. 2010, 64:660-668.
24. Singh C.K., Kumar A., Lavoie H.A., Dipette D.J., Singh U.S. Diabetic complications in pregnancy: is resveratrol a solution?. Exp. Biol. Med. (Maywood) 2013, 238:482-490.
25. Solomon J.M., Pasupuleti R., Xu L., McDonagh T., Curtis R., DiStefano P.S., Huber L.J. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol. Cell Biol. 2006, 26:28-38.
26. Sugino T., Maruyama M., Tanno M., Kuno A., Houkin K., Horio Y. Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells. FEBS Lett. 2010, 584:2821-2826.
27. Widlund A.L., Baur J.A., Vang O. mTOR: more targets of resveratrol?. Expert Rev. Mol. Med. 2013, 15:e10.
28. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.